ECM
ROIVW

ExodusPoint Capital Management’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

ExodusPoint Capital Management’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,563
Closed -$15K – 2437
2022
Q2 		$15K Hold
24,563
– – ﹤0.01% 1859
2022
Q1 		$22K Hold
24,563
– – ﹤0.01% 2102
2021
Q4 		$50K Buy
+24,563
New +$37.5K ﹤0.01% 2032

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

ExodusPoint Capital Management's ROIVW Position: Q3 2022 in Review

ExodusPoint Capital Management sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2022, closing a stake of 24,563 shares — an estimated $15K sold.

ExodusPoint Capital Management first reported a position in ROIVW in Q4 2021 and held it in 3 quarters. The position peaked at $50K in Q4 2021. 30 funds tracked by Wall St. Rank hold ROIVW as of Q3 2022.

  • ExodusPoint Capital Management reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 24,563 Roivant Sciences Ltd. Warrant shares in Q3 2022, an estimated $15K.
  • ExodusPoint Capital Management first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 3 quarters.
  • ExodusPoint Capital Management's Roivant Sciences Ltd. Warrant position peaked at $50K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.